close 74% rachunków inwestorów detalicznych odnotowuje straty w wyniku handlu kontraktami CFD u niniejszego dostawcy. Inwestowanie wiąże się z ryzykiem i nie jest odpowiednie dla wszystkich inwestorów. Kontrakty CFD są złożonymi instrumentami i wiążą się z dużym ryzykiem szybkiej utraty środków pieniężnych z powodu dźwigni finansowej. 74% rachunków inwestorów detalicznych odnotowuje straty w wyniku handlu kontraktami CFD u niniejszego dostawcy. Upewnij się, czy rozumiesz, jak działają kontrakty CFD, i czy możesz pozwolić sobie na wysokie ryzyko utraty pieniędzy.
Change languagePolski
Pulpit

LLY

977.55

-2.54%↓

JNJ

238.59

-2.76%↓

ABBV

231.29

-1.91%↓

NVS

160.78

-2.45%↓

AZN

197.28

-2.62%↓

LLY

977.55

-2.54%↓

JNJ

238.59

-2.76%↓

ABBV

231.29

-1.91%↓

NVS

160.78

-2.45%↓

AZN

197.28

-2.62%↓

LLY

977.55

-2.54%↓

JNJ

238.59

-2.76%↓

ABBV

231.29

-1.91%↓

NVS

160.78

-2.45%↓

AZN

197.28

-2.62%↓

LLY

977.55

-2.54%↓

JNJ

238.59

-2.76%↓

ABBV

231.29

-1.91%↓

NVS

160.78

-2.45%↓

AZN

197.28

-2.62%↓

LLY

977.55

-2.54%↓

JNJ

238.59

-2.76%↓

ABBV

231.29

-1.91%↓

NVS

160.78

-2.45%↓

AZN

197.28

-2.62%↓

Strona główna・Stock List・Nektar Therapeutics
Search

Nektar Therapeutics

Open

71.55 -0.54

Strong Buy

Price update 5 mar 2026, 19:55 UTC

BuySell

Overview

Share price change

24h

Current

Min

70.72

Max

74.54

Key metrics

By Trading Economics

Income

6.1M

-36M

Sales

615K

12M

EPS

-1.87

Profit margin

-301.289

Employees

61

EBITDA

6.9M

-29M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+90.66% upside

Dividends

By Dow Jones

Next Earnings

12 mar 2026

Market Stats

By TradingEconomics

Market Cap

773M

1.9B

Previous open

72.09

Previous close

71.55

Technical Score

By Trading Central

Confidence

Strong Bearish Evidence

0.5949 / 0.7406 Support & Resistance

Nektar Therapeutics Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

4 mar 2026, 23:39 UTC

Hot Stocks

Stocks to Watch: Broadcom, StubHub, PepGen, Veeva Systems

DJ

Read

4 mar 2026, 23:20 UTC

Earnings

Broadcom Sales Rise as AI Developers Build More Products and Agents -- Update

DJ

Read

4 mar 2026, 21:43 UTC

Earnings

Broadcom Logs Higher Sales, Authorizes $10 Billion Buyback Amid Climbing AI Demand

DJ

Read

4 mar 2026, 23:48 UTC

Market Talk

Nikkei May Rise After Recent Selloffs -- Market Talk

DJ

Read

4 mar 2026, 23:33 UTC

Market Talk
Major News Events

Gold Edges Higher Amid Ongoing U.S.-Iran Conflict -- Market Talk

DJ

Read

4 mar 2026, 23:24 UTC

Market Talk

RBA on Track to Raise Rates, but What's the Rush? -- Market Talk

DJ

Read

4 mar 2026, 22:30 UTC

Earnings

Ecopetrol: Distribution Equivalent to a Payout of 50.1% of Ecopetrol S.A.'s Net Income in 2025 >EC

DJ

Read

4 mar 2026, 22:30 UTC

Earnings

Ecopetrol: Payment of Dividends Proposed to Be Made No Later Than April 30 >EC

DJ

Read

4 mar 2026, 22:30 UTC

Earnings

Ecopetrol: Earnings Distribution Proposes Ordinary Div Distribution of COP110 per Shr >EC

DJ

Read

4 mar 2026, 22:13 UTC

Earnings

Vermilion Energy: Expects Full-Yr Production of 118,000 to 122,000 Boe/d (70% Natural Gas) >VET

DJ

Read

4 mar 2026, 22:13 UTC

Earnings

Vermilion Energy: Expects 1Q Production to Avg 122,000 to 124,000 Boe/d (70% Natural Gas) >VET

DJ

Read

4 mar 2026, 22:13 UTC

Earnings

Vermilion Energy 4Q EPS C$2.86 >VET

DJ

Read

4 mar 2026, 22:04 UTC

Market Talk

RBA Slipping Behind The Curve On Rates -- Market Talk

DJ

Read

4 mar 2026, 21:53 UTC

Earnings

Lithium Americas 4Q Rev $66.8M >LAC

DJ

Read

4 mar 2026, 21:53 UTC

Earnings

Lithium Americas 4Q Loss/Shr 52c >LAC

DJ

Read

4 mar 2026, 21:52 UTC

Earnings

Broadcom Earnings Beat Estimates as AI Demand Remains Strong -- Barrons.com

DJ

Read

4 mar 2026, 21:50 UTC

Earnings

These Stocks Are Today's Movers: Moderna, Coinbase, Strategy, CoreWeave, Micron, Sandisk, GitLab, and More -- Barrons.com

DJ

Read

4 mar 2026, 21:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

DJ

Read

4 mar 2026, 21:48 UTC

Earnings

Webull 4Q Rev $165.2M >BULL

DJ

Read

4 mar 2026, 21:48 UTC

Earnings

Webull 4Q EPS 1c >BULL

DJ

Read

4 mar 2026, 21:45 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

DJ

Read

4 mar 2026, 21:45 UTC

Market Talk

Canada Officials Might Need to Intervene to Spur Home Building -- Market Talk

DJ

Read

4 mar 2026, 21:40 UTC

Earnings

Broadcom Earnings Beat Estimates as AI Demand Remains Strong -- Barrons.com

DJ

Read

4 mar 2026, 21:36 UTC

Major News Events

Iran Conflict Spurs Rebound in U.S. Borrowing Costs -- Update

DJ

Read

4 mar 2026, 21:27 UTC

Earnings

Broadcom Earnings Beat Estimates as AI Demand Remains Strong -- Barrons.com

DJ

Read

4 mar 2026, 21:17 UTC

Market Talk

Energy Price Volatility Boosts Case for Climate-Tech Startups -- Market Talk

DJ

Read

4 mar 2026, 21:16 UTC

Earnings

Broadcom: Board Authorizes Share-Repurchase Program for Up to $10B of Common Stock >AVGO

DJ

Read

4 mar 2026, 21:15 UTC

Earnings

Broadcom 1Q EPS $1.50 >AVGO

DJ

Read

4 mar 2026, 21:15 UTC

Earnings

Broadcom 1Q Net $7.35B >AVGO

DJ

Read

4 mar 2026, 21:15 UTC

Earnings

Broadcom 1Q Rev $19.31B >AVGO

DJ

Read

Peer Comparison

Price change

Nektar Therapeutics Forecast

Price Target

By TipRanks

90.66% upside

12 Months Forecast

Average 129.86 USD  90.66%

High 165 USD

Low 102 USD

Based on 8 Wall Street analysts offering 12 month price targets forNektar Therapeutics - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

8 ratings

8

Buy

0

Hold

0

Sell

Based on 8 analysts giving stock ratings to Nektar Therapeutics - Dist in the past 3 months.

Technical Score

By Trading Central

0.5949 / 0.7406Support & Resistance

Short Term

Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Intermediate Term

Strong Bearish Evidence

All events are bearish.

Long Term

Bearish Evidence

All events are bearish.

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

Other stocks from the sector

LLY

Eli Lilly and Co.

977.55

↓-2.54%

JNJ

Johnson and Johnson

238.59

↓-2.76%

ABBV

AbbVie Inc

231.29

↓-1.91%

NVS

Novartis AG

160.78

↓-2.45%

AZN

AstraZeneca PLC

197.28

↓-2.62%
help-icon Live chat